Therapeutic hypothermia physiology and evidence Dr Sanjay Wazir - - PowerPoint PPT Presentation

therapeutic hypothermia
SMART_READER_LITE
LIVE PREVIEW

Therapeutic hypothermia physiology and evidence Dr Sanjay Wazir - - PowerPoint PPT Presentation

Therapeutic hypothermia physiology and evidence Dr Sanjay Wazir Consultant Neonatology Cloudnine hospital Gurgaon Objectives hypothermia treatment Why hypothermia Does it work especially the low cost options How to do it


slide-1
SLIDE 1

Therapeutic hypothermia – physiology and evidence

Dr Sanjay Wazir Consultant Neonatology Cloudnine hospital Gurgaon

slide-2
SLIDE 2

Objectives – hypothermia treatment

 Why hypothermia  Does it work especially the low cost options  How to do it  Which babies to be put into treatment

slide-3
SLIDE 3

Global burden

slide-4
SLIDE 4

Disease model

So not all babies who did not cry at birth need treatment

slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7

Target mechanisms in asphyxia

Multiple interventions have been tried but most have not shown benefit

slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10
slide-11
SLIDE 11

Hypothermia has a sustained benefit

slide-12
SLIDE 12

Temp Range- major trials

 NICHD trial- 33.4 ± 0.4 °C  TOBY trial – 33.5 ± 0.5 °C  ICE trial – 33.8 ± 0.4 °C

This is the basis why most trails have stuck to this range

slide-13
SLIDE 13

Phases of cooling

Techniques for therapeutic hypothermia during transport and in hospital for perinatal asphyxial encephalopathy. Nicola J. Robertson, Giles S. Kendall, Sudhin Thayyil

Induction

  • Earlier the cooling, better
  • utcome
  • Passive cooling post reusus
  • Neuro exam before induction
  • ? Speed of induction
  • Overshoot common
slide-14
SLIDE 14

Phases of cooling

Maintenance  33-34 C  Prevent fluctuations- servo better  Avoid cold injury to skin  Prevent displacement

  • f temp probe

 Nursing  Monitoring

slide-15
SLIDE 15

Phases of cooling

Re-warming  Slow 0.2-0.5 C/hr  NO rapid rewarming

 Adult studies-poor

  • utcome

 ? Hypotension due to vasodilatation or hyperkalema/hypoglycem ia  Rebound seizures reported  Not reported in RCT’s

 Monitor few hours after normothermia to prevent rebound hyperthermia

slide-16
SLIDE 16

Cooling Equipment-manual and semi-automated devices

Techniques for therapeutic hypothermia during transport and in hospital for perinatal asphyxial encephalopathy. Nicola J. Robertson, Giles S. Kendall, Sudhin Thayyil

slide-17
SLIDE 17

Cooling Equipment- Automated (servo) devices

Techniques for therapeutic hypothermia during transport and in hospital for perinatal asphyxial encephalopathy. Nicola J. Robertson, Giles S. Kendall, Sudhin Thayyil

slide-18
SLIDE 18

Cooling equipment-low cost devices

 Passive cooling  Cool gel/Ice packs  Fans  Water bottles  Phase-changing material

slide-19
SLIDE 19
  • 18 babies cooled passively
  • Room temp 24 C
  • Barbiturate, opiates and benzodiazepams

used if temp not coming down

  • Then active cooling with cool gel packs
  • 4/18 (22%) did not require any active

cooling at all.

  • 14 newborns (78%) were actively cooled

with ice packs over a total of 9.6 ± 7.5 hours

Daetwyler K et al. Feasibility and safety of passive cooling in a cohort of asphyxiated newborn infants. Swiss Med Wkly. 2013;143:w13767

Passive cooling

slide-20
SLIDE 20

 Thomas et al-Indian Pediatr. 2011 Jun 7;48(6):445-51  Cloth covered ice gel packs in 20 babies-

 Induction achieved -mea±n 52 mins),  stable maintenance 33.01±0.4 and smooth re-warming (0.48±0.07C)

Cool gel/Ice Packs

slide-21
SLIDE 21
slide-22
SLIDE 22

Monitoring -Clinical

 Temperature- continuous core (rectal/esophageal) and skin

 Record q15 mins for 1st 4 hour, then q1h

 Vitals- continuous HR, SPO2, BP and urine

  • utput

 Should have ECG leads,  invasive BP-art line/UA,  Central access (UV) as far as possible,  SPO2 monitoring,  Urinary cath/bag  Record hourly  Change position and check skin for cold injury q4h

slide-23
SLIDE 23

Inclusion Criteria for Brain Cooling

A.GA > 35 Wks /Birth Weight > 1800 Gms /<6 Hrs of age

  • B. Physiological criteria –Any1 of following

1.ABG (UC/1st postnatal hr) PH<7 or ABE > -12

  • 2. Apgar score <5 at 5 min

3.Ventilation required for at Least 10 min

  • C. Neurological Criteria :

Seizure or Evidence of Moderate and Severe encephalopathy (3 of 6 criteria in modified Criteria)

slide-24
SLIDE 24

MODIFIED SARNAT’S STAGING Shankaran et

  • al. NICHD

trial NEJM 2005

slide-25
SLIDE 25

OUTBORN

1.GA > 35 wks / Birth Weight > 1800 g/ < 6 hrs of age

  • 2. Physiological Criteria – Newborn who did not cry immediately after

Birth/ Required resuscitation/APGAR score < 5 at 5 min(if avail.)

  • 3. Neurological Criteria –Seizures or evidence of encephalopathy

The newborn should fulfill criteria 1, 2,and 3.If not ,do not use the product

Department of Neonatology , Christian Medical College, Vellore, India

slide-26
SLIDE 26

Exclusion Criteria

 > 6 hours of age  Major congenital abnormalities,  Imperforate anus  significant head trauma or skull fracture  Coagulopathy with active bleeding  Severe PPHN/ possible need for NO  Infants < 1,800g-birth weight

slide-27
SLIDE 27
slide-28
SLIDE 28

Stopping cooling prior to 72 hours

 Persistent hypoxemia in 100 % oxygen  Life threatening coagulopathy  Arrthymia requiring medical treatment (not sinus bradycardia)  Decision on withdrawal of care-signs of irreversible brain damage

slide-29
SLIDE 29

Clinical Monitoring

Heart rate Q 1hrly Respiratory Rate Q 1hrly Blood pressure Q 1hrly Spo2 Q 1hrly –more frequent if hypotensive Rectal Temperature Q 1hrly Skin Temp Q 1hrly Neurological examination At recruitment prior to cooling and q 24 hrly till normal and discharge(Thompson scoring) Urine Output Q 6hrly Skin Beakdown/redness Q 4 hrly

slide-30
SLIDE 30

Lab Monitoring

Baseline 24 hrs 48 hrs 72 hrs

  • S. Electrolyte

Y Y Blood urea Y Y

  • S. Creatinine

Y Y Blood sugar PT/APTT Y Y Y Y Hb, TLC, DLC,Plt. Y Y Y SGOT/SGPT Y ECG When Clinically Indicated HR < 80/min

slide-31
SLIDE 31

NEUROLOGICAL MONITORING

 Neurological assessment at least once a day till rewarming- eg Sarnat/Thompson  Formal eg Amiel-Tison/Hammersmith NNE/TIMP (test for infant motor performance) at 1 week or discharge  aEEG  Neuroimaging -Ultra sound/MRI with MRS

slide-32
SLIDE 32

ADVERSE OUTCOME

 Sclerema and Subcutaneous fat necrosis  Skin erythema  Pulmonary hemorrhage  Renal failure  Increased blood viscosity- hemoconcentration, hyperviscosity  DIC  Hypoglycemia  Acid-base and electrolyte disturbances  Increased risk of infections  Hypotension- marked decrease in myocardial contractility and cardiac output in experimental animal models  Sudden cardiac arrest, VT,VF  Pulmonary vasoconstriction.

slide-33
SLIDE 33

Conclusion

 Asphyxia - huge burden but now interventions for reduction available  Selection of babies is key to optimum outcome  Servo controlled devices are good but expensive  Low cost models are available – look very promising but would need long term data

slide-34
SLIDE 34

THANK YOU